Minerva Neurosciences
NERV
33 hedge funds and large institutions have $16.3M invested in Minerva Neurosciences in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 14 reducing their positions, and 6 closing their positions.
236% more call options, than puts
Call options by funds: $225K | Put options by funds: $67K
0.31% less ownership
Funds ownership: 6.07% → 5.76% (-0.31%)
2% less capital invested
Capital invested by funds: $16.6M → $16.3M (-$275K)
6% less funds holding
Funds holding: 35 → 33 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
79% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$134K |
| 2 |
B
Bailard
Foster City,
California
|
+$18.7K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$13.1K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$11.5K |
| 5 |
SMH
Sanders Morris Harris
Houston,
Texas
|
+$9.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$281K |
| 2 |
Morgan Stanley
New York
|
-$158K |
| 3 |
Renaissance Technologies
New York
|
-$154K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$135K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$68.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $4K | -$2.82K | -459 | -46% |
|
|
TFM
27
TFC Financial Management
Boston,
Massachusetts
| $1K | – | – | – |
|
28
JP Morgan Chase
New York
| $1K | +$497 | +81 | New |
|
29
BNP Paribas Financial Markets
Paris,
France
| $442 | – | – | – |
|
|
AIM
30
Anchor Investment Management
Columbia,
South Carolina
| $83 | – | – | – |
|
|
31
Dimensional Fund Advisors
Austin,
Texas
| – | -$281K | -43,779 | Closed |
|
|
VF
32
Virtu Financial
New York
| – | -$24K | -3,762 | Closed |
|
|
RJFSA
33
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| – | -$16K | -2,500 | Closed |
|
34
Jane Street
New York
| – | -$9K | -1,365 | Closed |
|
35
Group One Trading
Chicago,
Illinois
| – | -$8.28K | -1,349 | Closed |
|
|
ACM
36
Aquatic Capital Management
Chicago,
Illinois
| – | -$2K | -275 | Closed |
|
37
Bank of America
Charlotte,
North Carolina
| – | -$528 | -86 | -83% |
|
38
Simplex Trading
Chicago,
Illinois
| – | +$37 | +6 | New |
|
NERV Hedge Fund Activity: Q1 2022 in Review
33 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q1 2022, worth a combined $16.3M — down 1.7% from $16.6M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of NERV and 4 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 3 added.
The largest buyer was Fidelity Investments, adding an estimated $134K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $281K sold.
- 33 institutional investors held Minerva Neurosciences (NERV) as of Q1 2022, down from 35 in Q4 2021.
- Funds reported $16.3M of Minerva Neurosciences stock for Q1 2022, down 1.7% quarter-over-quarter.
- 4 funds opened new Minerva Neurosciences positions in Q1 2022 and 6 closed out, a net change of -2 holders.
- The largest Minerva Neurosciences buyer in Q1 2022 was Fidelity Investments, an estimated $134K added.
- The largest Minerva Neurosciences seller in Q1 2022 was Dimensional Fund Advisors, an estimated $281K sold.
Based on aggregated 13F filings for Q1 2022.